Advertisement

Anfälle und Myoklonien

  • P. Hopp
  • S. Noachtar
  • H. Stefan

Zusammenfassung

Die Häufigkeit von epileptischen Anfällen liegt bei etwa 15% aller intensivbe-handlungsbedürftigen neurologischen und internistischen Erkrankungen [11]. Aber auch synkopalen, psychogenen und tetanischen Anfällen kann eine wichtige Rolle zukommen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aicardi J (1992) Epilepsy and inborn errors of metabolism. In: Roger J, Dravet C, Dreifuss FE et al. (Hrsg) Epileptic syndromes in infancy, childhood and adolescence. Libbey, London, pp 97–102.Google Scholar
  2. 2.
    Brown P, Steiger MJ, Thompson PD et al. (1993) Effectiveness of Piracetam in cortical myoclonus. Mov Disord 8:63–68.CrossRefPubMedGoogle Scholar
  3. 3.
    Chapman AG (1986) Valproate and myoclonus. In: Fahn S, Marsden CD, Van Woert M (Hrsg) Adv Neurol 43. Raven, New York, pp 661–674.Google Scholar
  4. 4.
    Commission on Classification and Terminology of the International League against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489–501.CrossRefGoogle Scholar
  5. 5.
    Fahn S, Marsden CD, Van Woert M (1986) Definition and Classification of Myoclonus. In: Fahn S, Marsden CD, Van Woert M (Hrsg) Adv Neurol 43. Raven, New York, pp 1–5.Google Scholar
  6. 6.
    Fahn S (1986) Posthypoxic action myoclonus: literature review update. In: Fahn S, Marsden CD, Van Woert M (Hrsg) Adv Neurol 43. Raven, New York, pp 157–169.Google Scholar
  7. 7.
    Ikeda A, Shibasaki H, Tashiro K et al. (1996) Clinical trial of Piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. Mov Disord 11:691–700.CrossRefPubMedGoogle Scholar
  8. 8.
    Jumao-as A, Brenner RP (1990) Myoclonic status epilepticus: A clinical and electroencephalographic study. Neurology 40:1199–1202.CrossRefPubMedGoogle Scholar
  9. 9.
    Lance JW (1986) Action myoclonus, Ramsay Hunt syndrome, and other cerebellar myoclonic syndromes. In: Fahn S, Marsden CD, Van Woert M (Hrsg) Adv Neurol 43. Raven, New York, pp 33–55.Google Scholar
  10. 10.
    Lance JW, Adams RD (1963) The syndrome of intention or action myoclonus as a sequel of hypoxic encephalopathy. Brain 86:111–136.CrossRefPubMedGoogle Scholar
  11. 11.
    Meyding-Lamadé U, Hacke W (1995) Der epileptische Einzelanfall — Diagnostik und Therapie in der Notfallsituation. Intens Notfallmed 32:229–235.Google Scholar
  12. 12.
    Obeso JA (1997) Classification, clinical features, and treatment of myoclonus. In: Watts RL, Koller WC (Hrsg) Movement disorders: neurological principles and practice. McGraw-Hill, New York, pp 541–550.Google Scholar
  13. 13.
    Obeso JA, Artieda J, Rothwell JC, Day B, Thompson P, Marsden CD (1989) The treatment of severe action myoclonus. Brain 112:765–777.CrossRefPubMedGoogle Scholar
  14. 14.
    Pappert EJ, Goetz CG (1995) Treatment of myoclonus. In: Kurlan R (ed) Treatment of movement disorders. Lippincott, Philadelphia, pp 247–336.Google Scholar
  15. 15.
    Pohlmann-Eden B et al. (1998) Parenterale Valproattherapie des posthypoxischen Myo-klonus. Abstractband, 15. Jahrestagung der Arbeitsgemeinschaft für Neurologische Intensivmedizin in der Deutschen Gesellschaft für Neurologie.Google Scholar
  16. 16.
    Pranzatelli MR (1994) Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists. Arch Neurol 51:605–617.CrossRefPubMedGoogle Scholar
  17. 17.
    Pranzatelli MR, Nadi NS (1995) Mechanism of action of antiepileptic and antimyoclon-ic drugs. In: Fahn S, Hallett M, Lüders HO, Marsden CD (eds) Adv Neurol 67. Raven, New York, pp 329–360.Google Scholar
  18. 18.
    Roger J et al. (1992) Progressive myoclonic epilepsies in childhood and adolescence. In: Roger J, Dravet C, Dreifuss FE et al. (eds) Epileptic syndromes in infancy, childhood and adolescence. Libbey, London, pp 363–379.Google Scholar
  19. 19.
    Schmidt D (1997) Epilepsie. Diagnostik und Therapie für Klinik und Praxis. Schatt-auer, Stuttgart.Google Scholar
  20. 20.
    Stefan H (1995) Epilepsien: Diagnose und Behandlung. Chapman & Hall, Weinheim.Google Scholar
  21. 21.
    Stefan H, Lesser RB (1994) Seizures. In: Hacke W et al. (eds) Neurocritical care. Springer, Berlin Heidelberg New York Tokyo, pp 277–284.CrossRefGoogle Scholar
  22. 22.
    Toro C, Hallett M (1995) Pathophysiology of myoclonic disorders. In: Watts RL, Koller WC (eds) Movement disorders: neurological principles and practice. McGraw-Hill, New York, pp 541–550.Google Scholar
  23. 23.
    Werhahn KJ, Brown P, Thompson PD, Marsden CD (1997) The clinical features and prognosis of posthypoxic myoclonus. Mov Disord 12:216–220.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • P. Hopp
  • S. Noachtar
  • H. Stefan

There are no affiliations available

Personalised recommendations